Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Broadfin Capital Thinks CAS Medical Systems Inc (CASM) Is Worth Some Cash

Even though passive “hedgies” do not benefit from the same amount of coverage as their activist peers, their moves should also be watched closely. In a 13G filing with the SEC, Kevin Kotler‘s hedge fund, Broadfin Capital, disclosed ownership of 1.3 million shares of CAS Medical Systems Inc (NASDAQ:CASM), which means that the hedge fund boosted its position in the company by almost 1.1 million shares. At the current price of the company’s stock, the 6.9% position held by Broadfin is worth $1.8 million.

CAS Medical Systems Inc (NASDAQ:CASM)

This big move is interesting, because the previous 13F filings of Kevin Kotler’s hedge fund showed that Broadfin was mostly reducing its stake in CAS Medical since the first purchase made in the middle of 2011, when the hedge fund initiated its position by acquiring around 40,800 shares. However, a year later, the hedge fund upped the stake by almost 400%, and with the recent buy, Broadfin solidifies its position as one of the largest shareholders of the company.

In addition to Broadfin, some other hedge funds have been bullish according to Insider Monkey’s database of 13F filings. As follows, Ken Griffin’s Citadel Investment Group and Jim Simons’ Renaissance Technologies also disclosed ownership of CAS Medical Systems Inc (NASDAQ:CASM) shares last quarter, although both were insignificant in comparison to Broadfin Capital’s position.

Recommended Reading:

Starboard Value Solidifies Position in Emulex Corporation (ELX), Seeks For Changes

What Jim Chanos Thinks About China, Apple Inc. (AAPL) & Where He’s Looking Next

Mario Gabelli On Tesla Motors Inc (TSLA) & Elon Musk: ‘I Am Not So Sure He Should Be Selling Direct’

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!